InMed Pharmaceuticals Inc Surges to 205th Most Traded Stock with 130787.47% Volume Spike

On June 2, 2025, InMed Pharmaceuticals Inc. (INM) experienced a significant surge in trading volume, reaching 4.49 billion, marking a 130787.47% increase from the previous day. This surge positioned INM as the 205th most traded stock of the day. The stock price of INM rose by 37.35%, marking the second consecutive day of gains, with a total increase of 39.59% over the past two days.

Analysts have attributed the rapid rise in INM stock to potential partnerships and licensing deals in the pipeline. These deals could enable broader market access and drive further growth for the company. The technical signal analysis revealed that the KDJ Golden Cross, which occurs when the fast line (K) and slow line (J) intersect above the 20 level, signaled a potential bullish trend reversal. This suggests that buyers are overcoming short-term selling pressure. The astronomical volume of 30.6 million shares, likely dwarfing average daily turnover, hints at a sudden rush of retail or algorithmic activity. The surge may stem from speculative retail buying or momentum-chasing algorithms reacting to the KDJ signal.

InMed's spike was idiosyncratic, not part of a broader sector rally. Investors likely targeted InMed specifically, possibly due to its smaller market cap and technical setup, rather than sector-wide optimism. The divergence from peers like AAP, AXL, and ALSN—all of which fell between 0.37% and 1.86%—supports the idea that InMed’s jump was a standalone event. Without insider trading clues or product updates, the most logical explanation is a self-reinforcing technical rally where algorithms and retail traders chased the same signal, amplifying the move far beyond fundamentals.